BioCentury
ARTICLE | Company News

Harvard Medical School other research news

August 2, 2004 7:00 AM UTC

Researchers published in Science that NSCLC cells expressing EGFr mutants with activating mutations in the kinase domain selectively activate Akt and STAT signaling pathways, which promote cell surviv...